Immunohistochemical detection of metallothionein and MIB1 in uterine cervical squamous lesions

International Journal of Gynecological Pathology

Volumn 17, Issue 1, 1998, Pages 29-35

  McCluggage, W Glen ^a   Maxwell, Perry ^a   Bharucha, Hoshang ^b  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia (CIN); Immunohistochemistry; Metallothionein; MIB1

Indexed keywords

METALLOTHIONEIN; MONOCLONAL ANTIBODY KI 67;

ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU;

EID: 0031964417     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199801000-00006     Document Type: Article

References (44)

1. Buckley CH, Butler EB, Fox H. Cervical intraepithelial neoplasia. J Clin Pathol 1982;35:1-13.
2. Fox H, Buckley CH. Current problems in the pathology of intraepithelial lesions of the uterine cervix. Histopathology 1990;17: 1-6.
3. Anderson MC, Brown CL, Buckley CH, et al. Current views on cervical intraepithelial neoplasia. J Clin Pathol 1991;44:969-78.
4. McCluggage WG, Buhidma M, Tang L, Maxwell P, Bharucha H. Monclonal antibody MIB1 in the assessment of cervical squamous intraepithelial lesions. Int J Gynecol Pathol 1996;15:131-36.
5. Mittal KR, Demopoulos RI, Goswami S. Proliferating cell nuclear antigen (Cyclin) expression in normal and abnormal cervical squamous epithelia. Am J Surg Pathol 1993;17:117-22.
6. Raju GC. Expression of the proliferating cell nuclear antigen in cervical neoplasia. Int J Gynecol Pathol 1994;12:337-41.
7. Kobayashi I, Matsuo K, Ishibashi Y, Kanda S, Satai H. The proliferative activity in dysplasia and carcinoma in situ of the uterine cervix analysed by proliferating cell nuclear antigen immunostaining and silver-binding argyrophilic nucleolar organiser region staining. Hum Pathol 1994;25:198-202.
8. Konishi I, Fujii S, Nonogoki H, Nanbu Y, Iwai T, Mori T. Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix. Cancer 1991;68: 1340-50.
9. Bulten J, Van der Laak JAWM, Gemmink JH, Pahlplatz MMM, de Wilde PCM, Hanselaar AGJM. MIB1, a promising marker for the classification of cervical intraepithelial neoplasia. J Pathol 1996; 178:268-73.
10. Al-Saleh W, Delvenne P, Greimers R, Fridman P, Doyen J, Boniver J. Assessment of Ki-67 antigen immunostaining in squamous intraepithelial lesions of the uterine cervix. Correlation with histological grade and human papilloma virus type. Am J Clin Pathol 1995;104:154-60.
11. Payne S, Kernohan NM, Walker F. Proliferation in the normal cervix and in preinvasive cervical lesions. J Clin Pathol 1996;49: 667-71.
12. Heatley MK. Proliferation in the normal cervix and in preinvasive cervical lesions (Editorial). J Clin Pathol 1996;49:957.
13. Kagi JHR. Overview of metallothionein. Methods Enzymol 1991; 205:613-26.
14. Ofner D, Maier H, Riedmann B, Bammer T, et al. Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumour stage and patient survival. Virchows Archiv 1994;425:491-7.
15. Ohshio G, Imamura T, Okada N, et al. Immunohistochemical study of metallothionein in pancreatic carcinomas. J Cancer Res Clin Oncol 1996;122:351-5.
16. Sunardhi-Widyaputra S, van den Oord JJ, Van Houdt K, De Ley M, Van Damme B. Identification of metallothionen and parathyroid hormone related peptide (PTHrP)-positive cells in salivary gland tumours. Path Res Pract 1995;191:1092-8.
17. Giuffre G, Barresi G, Sturniolo GC, Sarnelli R, D'Inca RD, Tuccari G. Immunohistochemical expression of metallothionein in normal human colorectal mucosa, in adenomas and in adenocarcinomas and their associated metastases. Histopathology 1996;29: 347-54.
18. Chin JL, Banerjee D, Kadhim SA, Kontozoglou TE, Chauvin PJ, Cherian MG. Metallothionein in testicular germ cell tumors and drug resistance. Cancer 1993;72:3029-35.
19. Bahnson RR, Banner BF, Ernstoff MS, et al. Immunohistochemical localization of metallothionein in transitional cell carcinoma of the bladder. J Urol 1991;146:1518-20.
20. Bahnson RR, Becich M, Ernstoff MS, Sandlow J, Cohen MB, Williams RD. Absence of immunohistochemical metallothionein staining in bladder tumor specimens predicts response to neoadjuvant cisplatin, methotrexate and vinblastine chemotherapy. J Urol 1994;152:2272-5.
21. Zeiger B, Hittmair A, Schir M, et al. Immunohistochemically demonstrated metallothionein expression in malignant melanoma. Histopathology 1993;23:257-64.
22. Nartey N, Cherian MG, Banerjee D. Immunohistochemical localization of metallothionein in human thyroid tumors. Am J Clin Pathol 1987;129:177-82.
23. Oyama T, Takei H, Hikino T, Iino Y, Nakajima T. Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis. Oncology 1996;53:112-7.
24. Fresno M, Wu W, Rodriguez JM, Nadji M. Localization of metallothionein in breast carcinomas. An immunohistochemical study. Virchows Archiv A Pathol Anat 1993;423:215-29.
25. Haerslev T, Jacobsen K, Nedergaard L, Zedeler K. Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastases. Path Res Pract 1994;190:675-81.
26. Bier B, Douglas-Jones A, Totsch M, et al. Immunohistochemical demonstration of metallothionein in normal human breast tissue and malignant breast lesions. Breast Cancer Res Treat 1994;30: 213-21.
27. Goulding H, Jasani B, Pereira H, et al. Metallothionein expression in human breast cancer. Br J Cancer 1995;72:968-72.
28. Douglas-Jones AG, Schmid KW, Bier B, et al. Metallothionein expression in duct carcinoma in situ of the breast. Hum Pathol 1995;26:217-22.
29. Schmid KW, Ellis IO, Gee JMW, et al. Presence and possible significance of immunocytochemically demonstrated metallothionein over-expression in primary invasive ductal carcinoma of the breast. Virchows Archiv A Pathol Anat 1993;422:153-9.
30. McCluggage WG, Bharucha H, Caughley LM, et al. Interobserver variation in the reporting of cervical colposcopic biopsy specimens: comparison of grading systems. J Clin Pathol 1996;49: 833-5.
31. McCluggage WG, Walsh MY, Thornton CM, et al. Inter and intraobserver variation in the histopathological reporting of cervical squamous intraepithelial lesions using a modified Bethesda grading system Br J Obstet Gynaecol (in press).
32. McCluggage WG, Maxwell P, McBride HA, Hamilton PW, Bharucha H. Monoclonal antibodies Ki-67 and MIB1 in the distinction of tuboendometrial metaplasia from endocervical adenocarcinoma and adenocarcinoma in situ in formalin-fixed material. Int J Gynecol Pathol 1995;14:209-16.
33. Van Hoeven KH, Radmondetta L, Koratich AJ, Bibbo M, Dunton CJ. Quantitative image analysis of MIB1 reactivity in inflammatory, hyperplastic and neoplastic endocervical lesions. Int J Gynecol Pathol 1997;16:15-21.
34. Hockenberg D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. BCL-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-6.
35. Harmsel BT, Smedts F, Kuijpers J, Jeunink M, Trimbos B, Ramaekers F. BCL-2 immunoreactivity increases with severity of CIN: a study of normal cervical epithelia, CIN, and cervical carcinoma. J Pathol 1996;179:26-30.
36. Kirkland JA, Stanley MA, Cellier K. Comparative study of histologic and chromosomal abnormalities in cervical neoplasia. Cancer 1967;20:1934-52.
37. Al-Nafussi AI, Hughes DE. Histological features of CIN III and their value in predicting invasive microinvasive squamous carcinoma. J Clin Pathol 1994;47:799-804.
38. Kelley SL, Basu A, Leicher BA, Hacker MP, Hamer DH, Lazo J. Overexpression of metallothionein confers resistance to anticancer drugs. Science 1988;241:1815-8.
39. Koropatnick J, Pearson J. Zinc treatment, metallothionein expression and resistance to cisplatin in mouse melanoma cells. Somat Cell Mol Genet 1990;16:529-37.
40. Alberts DS, Garcia D, Masson-Liddil L. Cisplatin in advanced cancer of the cervix: An Update. Semin Oncol 1991;18(Suppl 3): 11-24.
41. Cervellino JC, Araujo CE, Sanchez O, Miles H, Nishihama A. Cisplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix. Acta Oncol 1995;34:257-9.
42. Valle BL, Galdes A. The Metalobiochemistry of Zinc Enzymes. In: Meister A (ed.) Advances in Enzymology and Related Areas of Molecular Biology. New York: John Wiley and Sons, 1994:283-430.
43. Cherian MG. Nuclear and cytoplasmic localization of metallothionein in human liver during development and in tumor cells. In: Suzuki KT, Imura N, Kimura M (eds). Metallothionein III. Basel; Birkhauser, 1993;175-87.
44. Walboomers JMM, Meijer CJLM. Do HPV-negative cervical carcinomas exist? J Pathol 1997;181:253-4.